| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Tudor Pop
Rosalio Madrigal
Michael Rose
Tudor Pop
Michael Rose
| Share Statistics | INSP | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,022.9 | $389.6 | 55% |
|
| Shares Out (Mil) | 28.9 | 40.9 | 36% |
|
| Institutional Ownership | 98.9% | 82.8% | 83% |
|
| Float (Mil) | 23.3 | 35.5 | 31% |
|
| Beta | 0.67 | 0.85 | 39% |
|
| Avg Daily Volume (000s) | 922 | 298 | 68% |
|
| Price Change (52-week) |
(3.3%) | 63.7% | 49% |
|
| Growth | INSP | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 51.2% | 11.8% | 96% |
|
| Net Income (5yr) | 35.3% | (5.6%) | 88% |
|
| EPS (5yr) | 33.4% | 10.2% | 84 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (17.5%) | (15.5%) | 40% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 13 | 14 | 14 | |
| Current EPS | $0.087 | $1.248 | $1.538 | |
| Month Ago EPS | $0.087 | $1.247 | $1.537 | |
| # Rev Up | 1 | 0 | 2 | |
| # Rev Down | 0 | 2 | 0 | |
| Three Months Ago EPS | $0.151 | $0.899 | $1.281 | |
| Year/Year Chg | 770.0% | (74.5%) | (60.2%) | |
| Financials | INSP | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $899 | $141 | 49% |
|
| Net Income (TTM) (Mil) | $135 | ($9) | 64% |
|
| EPS (TTM) | $4.665 | ($0.400) | 85% |
|
| Operating Cash Flow (TTM) (Mil) | $157 | ($2) | 56% |
|
| Net Cash Flow (TTM) (Mil) | $21 | $1 | 62% |
|
| Long-Term Debt (Q1) (Mil) | $29 | $26 | 35% |
|
| Enterprise Value (Q1) (Mil) | $1,359 | $409 | 44% |
|
| Valuation | INSP | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.45 | 2.73 | 60% |
|
| P/E | 15.2 | 25.0 | 40% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.5 | 1.4 | 23% |
|
| Ratios | INSP | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 86.1% | 58.7% | 92% |
|
| Net Margin | 15.0% | (6.9%) | 72% |
|
| ROA | 15.6% | (12.2%) | 94% |
|
| ROE | 18.0% | (10.7%) | 76% |
|
| Liabilities to Assets | 10.8% | 47.2% | 6% |
|
| F-Score | 8 | 4 | 93% |
|
Passing Stock Screens
As of 10/2/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 13.0% |
| +/- S&P 500: | +5.5 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
